Roberto Iacovelli: Proud of being part of this achievement in renal cancer

Roberto Iacovelli shared on X:

“I am so proud of being part of this achievement in renal cancer and so proud of my team and Chiara Ciccarese helping me in enrolling and managing patients. Really committed to offering the best opportunities and improving research in kidney cancer.”

Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma

Authors: Toni K. Choueiri, Thomas Powles, Katriina Peltola, Guillermo de Velasco, Mauricio Burotto, Cristina Suarez, Pooja Ghatalia, Roberto Iacovelli, Elaine T.Lam, Elena Verzoni, Mahmut Gümüş, Walter M. Stadler, Christian Kollmannsberger, Bohuslav Melichar, Balaji Venugopal, Marine Gross-Goupil, Alexandr Poprach, Maria De Santis, Fabio A. Schutz, Se Hoon Park, Dmitry A. Nosov, Camillo Porta, Jae Lyun Lee, Xavier Garcia-del-Muro, Elisa Biscaldi, Ray Manneh Kopp,  Mototsugu Oya, Li He, Aobo Wang, Rodolfo F.Perini, Donna Vickery, Laurence Albiges, Brian Rini,

Source: Roberto Iacovelli/X

For More Posts by Roberto Iacovelli, visit oncodaily.com

Dr. Roberto Iacovelli, is a medical oncologist at Fondazione Policlinico Gemelli IRCCS in Rome, Italy. With a focus on genitourinary cancers, his research focuses on metastatic renal cell carcinoma, prostate, and bladder cancer, exploring predictive factors and therapy sequencing.

Dr. Iacovelli’s contributions include over 150 publications in peer-reviewed journals and numerous awards for his work, including the ASCO Cancer Foundation Merit Award in 2011.